INTRODUCTION
Ticks and fleas are without doubt the most important ectoparasites of domestic dogs. Ticks are important because they can give rise to 'tick worry', transmit diseases to dogs, and may also bite and transmit diseases to the owners of the dogs 8, 20 . Fleas are of veterinary importance because they cause intense irritation in healthy dogs, flea-bite allergies in sensitised dogs and are the intermediate hosts of the larval stage of the dog tapeworm Dipylidium caninum. This tapeworm may also infect humans, and especially children 17, 18 . At least 22 ixodid tick species have been collected from dogs in South Africa 7,9,10,12 . The most commonly encountered of these are the southern African yellow dog tick, Haemaphysalis elliptica, the kennel tick, Rhipicephalus sanguineus, and the glossy brown tick Rhipicephalus simus. In the western Free State Province and the southwestern Western Cape Province R. simus is replaced by Rhipicephalus gertrudae 10, 12 . The 2 most important of the last 4 tick species are H. elliptica, the only proven vector of Babesia canis rossi 14 , the cause of virulent babesiosis in domestic dogs, and R. sanguineus the vector of Ehrlichia canis, the cause of ehrlichiosis in dogs 4 . Both ticks are also capable of transmitting Rickettsia conorii, the cause of tick-bite fever or tick typhus in humans 3, 13, 16 12 and from January to April in northeastern KwaZulu-Natal Province, South Africa 7 . The most commonly encountered flea on dogs in South Africa is the cat flea, Ctenocephalides felis 19 . The numbers of Ctenocephalides spp., amongst which C. felis was predominant, increased on kennelled dogs, on which no insecticide was used, from very low numbers in winter to reach a peak during late summer, decreasing again during autumn 5 . Effective control of C. felis will reduce irritation in healthy dogs, while absolute control is necessary when dogs display flea-bite allergies. Control of both C. felis and D. caninum is necessary to reduce the likelihood of infection in dogs and humans with this tapeworm.
The present paper describes an efficacy study in kennelled dogs artificially infested with adult H. elliptica and C. felis and to which a combination of the insecticides cyphenothrin (40 %) and pyriproxyfen (2 %) (Sergeant's Gold ® : Sergeant's Pet Care Products, Omaha, USA) was applied in a spot-on formulation.
MATERIALS AND METHODS
The study was a parallel group design, blinded, randomised, controlled efficacy study. Although it was not a good clinical practice investigation, it was carried out in line with the VICH GL9 guideline on good clinical practice 1 . The study was conducted on 2 groups of dogs, each consisting of 6 animals. Each group comprised 3 male and 3 female dogs, all more than 6 months old, and weighing between 10.6 kg and 16.4 kg, with hair-lengths varying between 18.7 mm and 60.0 mm. Each dog was fitted with an electronic transponder with unique alphanumeric numbers and harboured no ticks or fleas at the commencement of the study. The dogs had not been dipped in an acaricide/insecticide during the 8 weeks prior to the day of treatment, or treated with an acaricide/insecticide spot-on/spray during the preceding 12 weeks. They were individually housed in pens with concrete floors and a sleep bench in an indoors animal unit. No contact between dogs was possible. The animals were fed a commercially available animal feed once daily according to the manufacturer's recommendation. Potable water was available ad libitum. A laboratory-bred strain of H. elliptica, of which the larvae and nymphs were fed on rabbits, was used for artificial infestation of the dogs. The adult ticks used for these infestations were unfed, at least 1 week old and of a balanced sex ratio. Each dog was artificially infested with approximately 50 ticks on the days indicated in the experimental design summarised in Table 1 . A laboratory-bred strain of C. felis (routinely fed on cats) was used for all infestations. Fleas were unfed and of mixed sex. Each dog was infested with approximately 100 fleas on the days indicated in Table 1 . After treatment had been administered to the dogs, subsequent batches of fleas were not placed on or near the site at which the medication had been applied.
The study followed a randomised block design and the Day 5 flea counts of each dog were used for ranking and group allocation purposes. The 12 dogs were ranked, within sex, in descending order of individual flea counts. Within each sex animals were subsequently blocked into 2 blocks of 3 dogs each, and within each block dogs were randomly allocated to Groups 1 and 2. The groups were coded to blind the persons performing the posttreatment assessments. The dogs in Group 1 served as negative controls and received no treatment, whereas the dogs in Group 2 were treated with the product at a label recommended dosage of 3 m /dog.
Ticks were collected from the dogs 48 h after treatment and 48 h after each infestation by direct observation following parting of the hair and palpation. All ticks were removed and the condition of each tick was recorded using the parameters listed in Table 2 . Fleas were collected from the dogs 48 h after treatment and again after each infestation by combing the hair coat with a fine-toothed flea comb. Combing was performed by making several strokes with the comb in each area of the animal, each time following the lie of the hair. Movement, from one part of the animal's body surface to the next was via strokes overlapping each other, so that no site was left uncombed.
The primary criterion for the assessment of efficacy was based on the number of live ticks and fleas collected from dogs in the control group compared with the treated group on those days on which counts were conducted.
Percentage therapeutic efficacy against ticks was calculated as follows:
where Gmc = geometric mean number of live ticks (categories 1-3, Table 2 ) on dogs in the control group on Day 2 after treatment of the dogs in the treated group, and Gmt = geometric mean number of live ticks (categories 1-3) on dogs in the treated group on Day 2 after treatment.
Percentage residual efficacy was calculated as follows:
Residual efficacy (%) against ticks = 100 × (Gmc -Gmr) / Gmc, where Gmc = geometric mean number of live ticks (categories 1-3, Table 2 ) on dogs in the control group on Days 9, 16, 23, 30, 37 and 44 after treatment of the dogs in the treated group, and Gmr = geometric mean number of live ticks (categories 1-3, and 6) on dogs in the treated group on Days 9, 16, 23, 30, 37 and 44 after treatment. Even though category 6 ticks ( Table 2) were dead on the day of examination, they had managed to engorge before dying and were therefore included with the live ticks.
Efficacy against fleas was calculated as follows:
where mc = geometric mean number of live fleas on the control group of dogs (Group 1), and mt = geometric mean number of live fleas on the treated group (Group 2).
The groups were compared using an ANOVA with a treatment effect after logarithmic transformation of the tick and flea counts. The level of significance of the tests was set at 5 %. The residual period of protection against ticks and fleas was prescribed as the number of weeks post-treatment during which efficacy was ≥90 %.
RESULTS
Mean tick and flea counts and the efficacy of the product against H. elliptica and C. felis on the various days of assessment are summarised in Tables 3 and 4 . Therapeutic efficacy against H. elliptica based on geometric means was 83.1 %, and the residual period of protection against ticks during which efficacy was ≥90 % was 5 weeks. Therapeutic efficacy against C. felis was 97.5 %, and the residual period of protection was 5 weeks. 
DISCUSSION
It must be born in mind that a therapeutic efficacy of 83.1 % for the product investigated was obtained against H. elliptica that had already been attached for 2 days. On the other hand, its residual efficacy, which was ≥90 % for 5 weeks after treatment, was measured against ticks that were placed on dogs after the animals had been treated. Efficacy thus appears to be greater against unattached ticks than against attached ticks. This pattern of efficacy makes it a suitable parasiticide for use at the commencement of the tick season to prevent a rapid seasonal increase in the numbers of H. elliptica. Initial treatment should be administered during July in the Eastern and Western Cape Provinces 9,10 , during November in Free State Province 12 , during January in northern KwaZulu-Natal 7 , and according to the seasonal occurrence of ticks at other localities. Repeated application thereafter will ensure that tick numbers remain low during the remainder of the tick season.
The investigated product had a therapeutic efficacy of 97.5 % against the flea, C. felis. Its residual efficacy increased slightly to 100 % 9 days after treatment and remained at a high level up to and including 37 days after treatment. Its therapeutic and residual efficacy ensures its appropriateness for use during the commencement of the flea season when the numbers of C. felis are rapidly increas- 
